Form D · Pharmaceuticals
Amylyx Pharmaceuticals, Inc.
Cambridge, MA · CIK 0001658551
Offering snapshot reported Jul 1, 2020 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 17 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 18, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 1, 2020 | Initial | $30,000,000 | No comparison | 17 | SEC filing |
| Jan 28, 2020 | Amendment | $14,773,328 | $13,836,485vs Dec 31, 2019 | 37 | SEC filing |
| Dec 31, 2019 | Amendment | $936,843 | $0vs Dec 31, 2019 | 8 | SEC filing |
| Dec 31, 2019 | Initial | $936,843 | No comparison | 8 | SEC filing |
| Nov 20, 2018 | Initial | $12,978,100 | No comparison | 32 | SEC filing |
| Aug 4, 2017 | Initial | $1,832,698 | No comparison | 30 | SEC filing |
| Aug 22, 2016 | Amendment | $4,100,000 | $0vs Aug 22, 2016 | 19 | SEC filing |
| Aug 22, 2016 | Initial | $4,100,000 | No comparison | 19 | SEC filing |
| Nov 20, 2015 | Amendment | $1,440,000 | $0vs Nov 17, 2015 | 28 | SEC filing |
| Nov 17, 2015 | Initial | $1,440,000 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370064
Source: Form D, filed Jul 1, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Isaac Cheng | Director |
| Stephen Chubb | Director |
| Joshua Cohen | Director, Executive |
| Peter Finn | Executive |
| Walter Gilbert | Director |
| Justin Klee | Director, Executive |
| George Milne | Director |
| George M. Milne, Ph.D. | Director |
| Felix Von Coerper | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
43 Thorndike Street
Cambridge, MA, 02141
Cambridge, MA, 02141